Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
Go back to Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer| AGENUS (NASDAQ: AGEN) | Delayed: 6.68 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.68 | 52 Week High | $7.49 | |||
| Open | $6.68 | 52 Week Low | $2.61 | |||
| Day High | $6.68 | P/E | N/A | |||
| Day Low | $6.68 | EPS | $-1.10 | |||
| Volume | 20,412 | |||||
| (NASDAQ: GANX) | Delayed: 1.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.33 | 52 Week High | $ | |||
| Open | $1.33 | 52 Week Low | $ | |||
| Day High | $1.33 | P/E | N/A | |||
| Day Low | $1.33 | EPS | $ | |||
| Volume | 1 | |||||



